Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Facility"

1724 News Found

Co-Diagnostics JV leases manufacturing facility in Saudi Arabia
Medical Device | May 11, 2026

Co-Diagnostics JV leases manufacturing facility in Saudi Arabia

CoMira Diagnostics will manufacture PCR diagnostic instruments and medical consumables in Sudair Industrial City


Eye-Q upgrades advanced affordable eye care facility in Lucknow
Hospitals | May 09, 2026

Eye-Q upgrades advanced affordable eye care facility in Lucknow

The upgraded Rajajipuram centre now features enhanced retina services and advanced OCT technology


Biocon Biologics receives 5 procedural observations after US FDA inspection at Bengaluru facility
Biopharma | May 06, 2026

Biocon Biologics receives 5 procedural observations after US FDA inspection at Bengaluru facility

The US FDA completed a pre-license inspection of Biocon Biologics’ biosimilars manufacturing site at Biocon Park between April 20 and April 29, 2026


Novartis locks in $23 billion US expansion with seventh new facility
News | May 05, 2026

Novartis locks in $23 billion US expansion with seventh new facility

The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics


Alkem Laboratories receives 7 observations following US FDA inspection at Daman facility
Drug Approval | May 04, 2026

Alkem Laboratories receives 7 observations following US FDA inspection at Daman facility

The US regulator conducted an inspection at the Amaliya manufacturing plant between April 20 and May 1, 2026


Solara announces closure of US FDA inspection at Puducherry facility
Drug Approval | April 30, 2026

Solara announces closure of US FDA inspection at Puducherry facility

The Puducherry facility, dedicated to Ibuprofen and its derivatives, is equipped with advanced infrastructure to serve both domestic and international markets


Supriya Lifescience receives USFDA EIR with VAI classification for Maharashtra API facility
News | April 22, 2026

Supriya Lifescience receives USFDA EIR with VAI classification for Maharashtra API facility

Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States


Lilavati Hospital expands into Gujarat with GIFT City facility, launches free health camp
Hospitals | April 21, 2026

Lilavati Hospital expands into Gujarat with GIFT City facility, launches free health camp

The new facility is expected to significantly improve access to high-quality medical services for patients across Gujarat and neighbouring regions


Cipla receives two observations following USFDA inspection at Goa facility
Drug Approval | April 18, 2026

Cipla receives two observations following USFDA inspection at Goa facility

The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe


Former health minister Dr Harsh Vardhan visits Wadi Surgicals’ nitrile glove facility at AMTZ
Medical Device | April 16, 2026

Former health minister Dr Harsh Vardhan visits Wadi Surgicals’ nitrile glove facility at AMTZ

Visit underscores push for self-reliance in essential medical consumables and India’s ambition to become a global medtech manufacturing hub